The role of GOT1 in cancer metabolism

Front Oncol. 2024 Dec 24:14:1519046. doi: 10.3389/fonc.2024.1519046. eCollection 2024.

Abstract

GOT1, a cytoplasmic glutamic oxaloacetic transaminase, plays a critical role in various metabolic pathways essential for cellular homeostasis and dysregulated metabolism. Recent studies have highlighted the significant plasticity and roles of GOT1 in metabolic reprogramming through participating in both classical and non-classical glutamine metabolism, glycolytic metabolism, and other metabolic pathways. This review summarizes emerging insights on the metabolic roles of GOT1 in cancer cells and emphasizes the response of cancer cells to altered metabolism when the expression of GOT1 is altered. We review how cancer cells repurpose cell intrinsic metabolism and their flexibility when GOT1 is inhibited and delineate the molecular mechanisms of GOT1's interaction with specific oncogenes and regulators at multiple levels, including transcriptional and epigenetic regulation, which govern cellular growth and metabolism. These insights may provide new directions for cancer metabolism research and novel targets for cancer treatment.

Keywords: GOT1; cancer; cell metabolism; metabolic reprogramming; therapeutic target.

Publication types

  • Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Guangxi Science and Technology Project (Guangxi Science and Technology Base and Talent Special Project: Guike AD24010014), Guangxi Key Laboratory of reproductive health and birth defect prevention (21-220-22), Guangxi Clinical Research Center for Pediatric Diseases (Guike AD22035121), Self-Funded Program of Guangxi Health Commission (Z-A20240319), Guangxi Key Laboratory of Birth Defects and Stem Cell Biobank (ZTJ2020002).